Allergan Overview
- Year Founded
-
1983
- Status
-
Acquired/Merged
- Employees
-
18,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
13
- Investments
-
59
Allergan General Information
Description
Operator of a pharmaceutical company intended to focus on manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products. The company engages in medical aesthetics, eye care, central nervous system and gastroenterology and delivers innovative patient care, thereby enabling its customers to avail the solution for enhanced availability of medicinal products to cure several diseases in the market.
Contact Information
Website
www.allergan.comCorporate Office
- Clonshaugh Business and Technology Park
- Coolock
- Dublin D17 E400
- Ireland
Corporate Office
- Clonshaugh Business and Technology Park
- Coolock
- Dublin D17 E400
- Ireland
Allergan Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Allergan Comparisons
Industry
Financing
Details
Allergan Competitors (51)
One of Allergan’s 51 competitors is Abbott India, a Corporation company based in Mumbai, India.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Abbott India | Corporation | Mumbai, India | ||||
AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom | ||||
GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | ||||
Popular Pharmaceuticals | Private Debt Financed | Dhaka, Bangladesh | ||||
Pfizer Pakistan | Corporation | Karachi, Pakistan |
Allergan Patents
Allergan Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240066086-A1 | Topical hyperpigmentation compositions and method of use | Pending | 30-Aug-2022 | ||
US-20230321055-A1 | Preventive treatment of migraine | Pending | 09-Mar-2022 | ||
AU-2023231645-A1 | Preventive treatment of migraine | Pending | 09-Mar-2022 | ||
US-20230149392-A1 | Treatment of major depressive disorder | Inactive | 28-Oct-2021 | ||
US-20230130736-A1 | Methods of treating migraine | Pending | 27-Sep-2021 | A61K31/4439 |
Allergan Signals
Allergan Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Allergan Investments & Acquisitions (59)
Allergan’s most recent deal was a Accelerator/Incubator with Love Cork Screw for . The deal was made on 25-Jul-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Love Cork Screw | 25-Jul-2023 | Accelerator/Incubator | Beverages | ||
Stemson Therapeutics | 15-Jul-2021 | Early Stage VC | Biotechnology | ||
Soliton | 10-May-2021 | Merger/Acquisition | Other Devices and Supplies | ||
Luminera | 07-Oct-2020 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
Stemson Therapeutics | 16-Sep-2020 | Seed Round | Biotechnology |
Allergan Subsidiaries (7)
Company Name | Industry | Location | Founded |
---|---|---|---|
Medicines360 | Pharmaceuticals | San Francisco, CA | 2009 |
Keller Medical | Surgical Devices | Stuart, FL | |
Zeltiq Aesthetics | Other Healthcare Services | Pleasanton, CA | |
Auden Mckenzie | Pharmaceuticals | Ruislip, United Kingdom | |
The Allergan Foundation | Foundation | Irvine, CA |
Allergan Exits (5)
Allergan’s most recent exit was on 17-Nov-2016 from MedImmune (Brazikumab Global Rights). The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
MedImmune (Brazikumab Global Rights) | 17-Nov-2016 | Completed |
|
||
Zdravlje | 27-Dec-2012 | Completed |
|
||
Actavis Generics | 31-Oct-2012 | Completed |
|
||
M8 Pharmaceuticals | 14-Oct-2010 | Completed |
|
||
Anda (Distributors/Wholesale) | Merger/Acquisition | Completed |
Allergan FAQs
-
When was Allergan founded?
Allergan was founded in 1983.
-
Where is Allergan headquartered?
Allergan is headquartered in Dublin, Ireland.
-
What is the size of Allergan?
Allergan has 18,000 total employees.
-
What industry is Allergan in?
Allergan’s primary industry is Pharmaceuticals.
-
Is Allergan a private or public company?
Allergan is a Private company.
-
What is the current valuation of Allergan?
The current valuation of Allergan is
. -
What is Allergan’s current revenue?
The current revenue for Allergan is
. -
Who are Allergan’s investors?
NovaQuest Capital Management has invested in Allergan.
-
Who are Allergan’s competitors?
Abbott India, AstraZeneca, GlaxoSmithKline Consumer Nigeria, Popular Pharmaceuticals, and Pfizer Pakistan are some of the 51 competitors of Allergan.
-
When was Allergan acquired?
Allergan was acquired on 08-May-2020.
-
Who acquired Allergan?
Allergan was acquired by AbbVie.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »